(100 days)
No
The summary describes a clinical decision support system that uses "standardized rules" based on clinical protocols and policies to generate alerts. There is no mention of AI, ML, or any learning algorithms. The system appears to be rule-based rather than using AI/ML for analysis or decision making.
No
A therapeutic device directly treats or alleviates a medical condition. This device is a clinical decision support system that integrates and displays data, providing alerts and assistance to clinicians, but it does not directly administer therapy or provide a therapeutic effect.
No
The device is described as a "clinical decision support device" that integrates, analyzes, and displays data from other medical devices and healthcare information systems to create alerts. It is explicitly stated that it is "not intended to replace clinicians' judgment," but rather to "assist clinicians in making timely, informed, higher quality decisions." While it processes data that could be used in diagnosis, its primary function is to support decisions based on integrated data, not to perform a diagnosis itself.
Yes
The device description explicitly states it is a "clinical decision support device that integrates data from multiple sources including medical devices and healthcare information systems" and is accessed via a workstation or web browser. It does not mention any hardware components being part of the device itself, only that it integrates data from medical devices. The performance studies also focus on software and usability standards (IEC 62304, IEC 62366).
Based on the provided information, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- Intended Use: The intended use clearly states that the device "integrates, analyzes, and displays data from multiple sources including medical devices and healthcare information systems." It is a "clinical decision support device" that uses "standardized rules" based on "clinical protocols and policies" to create alerts. This describes a system that processes and presents existing patient data, not a device that performs tests on biological samples to diagnose or monitor a condition.
- Device Description: The description reinforces this by stating it "integrates data from multiple sources including medical devices and healthcare information systems" and provides information from "integrated data sources that monitor physiological parameters." This is consistent with a data aggregation and display system, not an IVD.
- Lack of IVD Characteristics: There is no mention of analyzing biological samples (blood, urine, tissue, etc.), reagents, or any other components typically associated with in vitro diagnostic testing.
Therefore, the Capsule Surveillance System falls under the category of a clinical decision support system that utilizes data from other medical devices and systems, rather than being an IVD itself.
N/A
Intended Use / Indications for Use
Capsule Surveillance is a clinical decision support device that integrates, analyzes, and displays data from multiple sources including medical devices and healthcare information systems. It uses standardized rules that are based on customers approved clinical protocols, and policies to create clinically relevant alerts in health care facilities when used by clinical physicians or appropriate medical staff under the direction of physicians. It is not intended to replace clinicians' judgment, but rather to assist clinicians in making timely, informed, higher quality decisions. Capsule Surveillance may be configured for secondary monitoring and alerting intended to be relied upon in deciding to take immediate clinical action. Capsule Surveillance may also be configured for remote display of physiological data and alerts not intended to be relied upon in deciding to take immediate clinical action.
Product codes
MWI
Device Description
The Capsule Surveillance System is a clinical decision support device that integrates data from multiple sources including medical devices and healthcare information systems.
The Capsule Surveillance Systems offers two methods of accessing the clinical application:
- . A workstation which is a dedicated desktop used exclusively to run the Capsule Surveillance System clinical application in kiosk mode.
- . The remote display which is any machine that accesses the Capsule Surveillance System via a web browser.
Use of the Capsule Surveillance System allows for simultaneous monitoring of different patients in a clinical setting, providing information from integrated data sources that monitor physiological parameters such as, pulse, respiratory rate, SpO2, temperature, and blood pressure.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
Not Found
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Used by clinical physicians or appropriate medical staff under the direction of physicians in healthcare facilities.
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies
Non-Clinical Tests - Harmonized Standards: The Capsule Surveillance System has passed all safety tests for demonstrated compliance with ANSI AAMI IEC 62304:2006/A1:2016 for Medical device software – Software life cycle processes, and ANSI AAMI IEC 62366-1:2015+AMDI:2020 (Consolidated Text) for Medical devices - Part 1 Application of usability engineering to medical devices, including Amendment 1.
Non-clinical Bench Tests: Human factors and usability testing has been completed. Testing in compliance with IEC 60601-1-8 for requirements for alarm systems in medical electrical equipment and medical electrical systems was completed, as well as certification to IEC 62304 for software lifecycle and IEC 62366.
Clinical Studies: The Capsule Surveillance System, like the predicate device, did not require clinical trials.
Key Results: No new issues of safety or effectiveness are introduced as a result of using this device. Performance characteristics are substantially equivalent to the Decision Health Patient Dashboard predicate device.
Key Metrics
Not Found
Predicate Device(s)
Reference Device(s)
Predetermined Change Control Plan (PCCP) - All Relevant Information
Not Found
§ 870.2300 Cardiac monitor (including cardiotachometer and rate alarm).
(a)
Identification. A cardiac monitor (including cardiotachometer and rate alarm) is a device used to measure the heart rate from an analog signal produced by an electrocardiograph, vectorcardiograph, or blood pressure monitor. This device may sound an alarm when the heart rate falls outside preset upper and lower limits.(b)
Classification. Class II (performance standards).
0
Image /page/0/Picture/0 description: The image shows the logo of the U.S. Food and Drug Administration (FDA). On the left is the Department of Health & Human Services logo. To the right of that is the FDA logo, which is a blue square with the letters "FDA" in white. To the right of the blue square is the text "U.S. FOOD & DRUG ADMINISTRATION" in blue.
January 14, 2022
Capsule Surveillance Technologies, SAS /Capsule Tech, Inc. Peter Kelley Director Quality & Regulatory 300 Brickstone Square Suite 203 Andover, Massachusetts 01810
Re: K213335
Trade/Device Name: Capsule Surveillance System Regulation Number: 21 CFR 870.2300 Regulation Name: Cardiac Monitor (Including Cardiotachometer And Rate Alarm) Regulatory Class: Class II Product Code: MWI Dated: December 13, 2021 Received: December 15, 2021
Dear Peter Kelley:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. Although this letter refers to your product as a device, please be aware that some cleared products may instead be combination products. The 510(k) Premarket Notification Database located at https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm identifies combination product submissions. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's
1
requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting of medical device-related adverse events) (21 CFR 803) for devices or postmarketing safety reporting (21 CFR 4, Subpart B) for combination products (see https://www.fda.gov/combination-products/guidance-regulatory-information/postmarketing-safety-reportingcombination-products); good manufacturing practice requirements as set forth in the quality systems (OS) regulation (21 CFR Part 820) for devices or current good manufacturing practices (21 CFR 4, Subpart A) for combination products; and, if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to https://www.fda.gov/medical-device-safety/medical-device-reportingmdr-how-report-medical-device-problems.
For comprehensive regulatory information about mediation-emitting products, including information about labeling regulations, please see Device Advice (https://www.fda.gov/medicaldevices/device-advice-comprehensive-regulatory-assistance) and CDRH Learn (https://www.fda.gov/training-and-continuing-education/cdrh-learn). Additionally, you may contact the Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website (https://www.fda.gov/medical-device-advice-comprehensive-regulatoryassistance/contact-us-division-industry-and-consumer-education-dice) for more information or contact DICE by email (DICE@fda.hhs.gov) or phone (1-800-638-2041 or 301-796-7100).
Sincerely,
for
LCDR Stephen Browning Assistant Director Division of Cardiac Electrophysiology, Diagnostics, and Monitoring Devices Office of Cardiovascular Devices Office of Product Evaluation and Quality Center for Devices and Radiological Health
Enclosure
2
Indications for Use
510(k) Number (if known)
Device Name Capsule Surveillance System
Indications for Use (Describe)
Capsule Surveillance is a clinical decision support device that integrates, analyzes, and displays data from multiple sources including medical devices and healthcare information systems. It uses standardized rules that are based on customers approved clinical protocols, and policies to create clinically relevant alerts in health care facilities when used by clinical physicians or appropriate medical staff under the direction of physicians. It is not intended to replace clinicians' judgment, but rather to assist clinicians in making timely, informed, higher quality decisions. Capsule Surveillance may be configured for secondary monitoring and alerting intended to be relied upon in deciding to take immediate clinical action.
Capsule Surveillance may also be configured for remote display of physiological data and alerts not intended to be relied upon in deciding to take immediate clinical action.
Type of Use (Select one or both, as applicable)
X Prescription Use (Part 21 CFR 801 Subpart D)
Over-The-Counter Use (21 CFR 801 Subpart C)
CONTINUE ON A SEPARATE PAGE IF NEEDED.
This section applies only to requirements of the Paperwork Reduction Act of 1995.
DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.
The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:
Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff(@fda.hhs.gov
"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."
3
| 510(k) Summary | |||
|---|---|---|---|
| I. SUBMITTER | |||
| Date Prepared | October 1st, 2021 | ||
| Submitter/Owner | Capsule Technologies, SAS / Capsule Tech, Inc. | ||
| FDA Establishment Number: 3003630387 | |||
| 300 Brickstone Square | |||
| Suite 203 | |||
| Andover, MA 01810 USA | |||
| Phone: 978-697-4364 | |||
| Key Contact | Peter Kelley | ||
| Director Quality & Regulatory | |||
| peter.kelley@philips.com | |||
| 510(k) Submission Type | This is a traditional 510(k). | ||
| II. DEVICE | |||
| Trade Name | Capsule Surveillance System | ||
| Common Name | Physiological Monitor | ||
| Classification Name | Panel & Name: Cardiovascular (OHT2) | ||
| Subpart & Division: Cardiac Electrophysiology, Diagnostics, and | |||
| Monitoring Devices (DHT2A) | |||
| 21 CFR 870.2300 | |||
| Regulatory Class: Class II | |||
| Product Code: MWI | |||
| III. PREDICATE DEVICE | |||
| 510(k) No. | Company Name | ||
| Device Name | Product | ||
| Code | |||
| Predicate Device | K142106 | Decisio Health, Inc.'s Decision Health | |
| Patient Dashboard | MWI | ||
| Reference Device | K130208 | Cardiopulmonary Corp.'s Bernoulli | |
| Enterprise Software | MHX, | ||
| MSX, | |||
| PFY |
4
IV. DEVICE DESCRIPTION
Capsule Surveillance System - description of the device per 21 CFR 807.92(a) (4)
The Capsule Surveillance System is a clinical decision support device that integrates data from multiple sources including medical devices and healthcare information systems.
The Capsule Surveillance Systems offers two methods of accessing the clinical application:
- . A workstation which is a dedicated desktop used exclusively to run the Capsule Surveillance System clinical application in kiosk mode.
- . The remote display which is any machine that accesses the Capsule Surveillance System via a web browser.
Use of the Capsule Surveillance System allows for simultaneous monitoring of different patients in a clinical setting, providing information from integrated data sources that monitor physiological parameters such as, pulse, respiratory rate, SpO2, temperature, and blood pressure.
V. INDICATIONS FOR USE
Intended Use as required per 21 CFR 807.92(a)(5)
The Capsule Surveillance is a clinical decision support device that integrates, and displays data from multiple sources including medical devices and healthcare information systems. It uses standardized rules that are based on customers approved clinical practices, protocols, and policies to create clinically relevant alerts in health care facilities when used by clinical physicians or appropriate medical staff under the direction of physicians. It is not intended to replace clinicians' judgment, but rather to assist clinicians in making timely, informed, higher quality decisions.
Capsule Surveillance may be configured for secondary monitoring and alerting intended to be relied upon in deciding to take immediate clinical action.
Capsule Surveillance may also be configured for remote display of physiological data and alerts not intended to be relied upon in deciding to take immediate clinical action.
Comparison of Intended Uses for Subject Device and Predicate
| Name | Indications for Use/Intended Use |
|---|---|
| Capsule | |
| Surveillance | |
| System | |
| Subject Device | The Capsule Surveillance is a clinical decision support device that integrates, |
| analyzes, and displays data from multiple sources including medical devices | |
| and healthcare information systems. It uses standardized rules that are based | |
| on customers approved clinical practices, protocols, and policies to create | |
| clinically relevant alerts in health care facilities when used by clinical | |
| physicians or appropriate medical staff under the direction of physicians. It is |
5
| | not intended to replace clinicians' judgment, but rather to assist clinicians in
making timely, informed, higher quality decisions. |
|----------------------------------------------------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| | Capsule Surveillance may be configured for secondary monitoring and
alerting intended to be relied upon in deciding to take immediate clinical
action. |
| | Capsule Surveillance may also be configured for remote display of
physiological data and alerts not intended to be relied upon in deciding to take
immediate clinical action. |
| K142106
Decisio Health
Patient
Dashboard
Predicate | The Decisio Health Patient Dashboard is a decision support device indicated
for aggregating, displaying, and managing physiologic and other patient
information. This information is generated by third party medical devices and
patient information systems. The device performs automated calculations on
patient data collected by third party devices based on approved clinical
protocols at patient care facilities. The Decisio Health Patient Dashboard is
intended for use by clinicians in healthcare facilities. |
| VI. COMPARISON OF TECHNOLOGICAL CHARACTERISTICS WITH THE PREDICATE DEVICE | |
|---|---|
| Similarities | |
| Item of Comparison | Description/Rationale |
| Target Populations | Both devices are intended to be used by trained clinicians. |
| Environment of Use | Both devices are intended to be used in a hospital setting. |
| Matrix and Detailed Views | Both devices allow for matrix or multi-patient simultaneous monitoring, as well as detailed views/monitoring of single patients. |
| Data Input | Both devices use input from EMR systems as well as medical devices via HL7 feed for monitoring |
| Differences | |
| Item of Comparison | Description/Rationale |
| Methods for Accessing the Application | The subject Capsule Surveillance System allows access via a workstation or remotely via a web browser. The predicate Decisio Health Patient Dashboard allows access through a computer, while also permitting access through a patient monitor or mobile device. |
Substantial Equivalence Summary
Operational and technological characteristics form the basis for the determination of substantial equivalence of the Capsule Surveillance System with the legally marketed predicate devices (K142106). The Capsule Surveillance System is substantially equivalent to the predicate devices.
6
PERFORMANCE DATA VII.
Non-Clinical Tests - Harmonized Standards
The Capsule Surveillance System has passed all safety tests for demonstrated compliance with the harmonized standards below.
| Standard | FDA Recognition # | Title # |
|---|---|---|
| ANSI AAMI IEC | ||
| 62304:2006/A1:2016 | 13-79 | Medical device software – Software life cycle processes [Including Amendment 1 |
| (2016)] | ||
| ANSI AAMI IEC | ||
| 62366- | ||
| 1:2015+AMDI:2020 | ||
| (Consolidated Text) | 5-129 | Medical devices - Part 1 Application of usability engineering to medical devices, |
| including Amendment 1 |
Non-clinical Bench Tests
Human factors and usability testing has been completed. Furthermore, testing in compliance with IEC 60601-1-8 for requirements for alarm systems in medical electrical equipment and medical electrical systems was completed, as well as certification to IEC 62304 for software lifecycle and IEC 62366.
No new issues of safety or effectiveness are introduced as a result of using this device.
Clinical Studies
The Capsule Surveillance System, like the predicate device, did not require clinical trials.
FDA recognized standards, FDA guidance documents, harmonized standards, verification and validation, software validation, usability validation, and risk management activities have taken place for the Capsule Surveillance System.
Based upon the design, intended use, indications for use, classification, usability and safety testing the Capsule Surveillance System is substantially equivalent to the listed predicate device.
No new issues of safety or effectiveness are introduced as a result of using this device.
CONCLUSIONS VIII.
The results of the substantial equivalence assessment, taken together with non-clinical bench testing, electrical safety and electromagnetic compatibility, software verification and validation,
7
human factors and usability demonstrate that the Capsule Surveillance System does not raise additional questions of safety and effectiveness when compared to the predicate, performs as intended, and has performance characteristics that are substantially equivalent to the Decision Health Patient Dashboard predicate device.